Cost‐effectiveness of ultrasound‐guided liver biopsy
Tousif Pasha, Sherine Gabriel, Terry Therneau, E. Rolland Dickson, Keith D. Lindor – 30 December 2003 – The risk of a major complication from “blind” percutaneous liver biopsy is reported to be in the range of 0.24% to 3.8%. In a recent randomized trial, patients whose liver biopsies were performed with ultrasonography had a significant reduction in complications requiring hospitalization compared with patients without ultrasound‐guided biopsies (0.5% vs. 2.2%, P < .05).